Spinal NTS2 receptor activation reverses signs of neuropathic pain
- 11 June 2013
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 27 (9) , 3741-3752
Abstract
Management of painful peripheral neuropathies remains challenging, since patients with chronic pain respond poorly to the available pharmacopeia. In recent years, the G‐protein‐coupled receptor neurotensin (NT) type 2 (NTS2) emerged as an attractive target for treating transitory pain states. To date, however, there is no evidence for its role in the regulation of chronic peripheral neuropathies. Here, we found that NTS2 receptors were largely localized to primary afferent fibers and superficial dorsal horns. Changes in the time course of the gene expression profile of NT, NTS1, and NTS2 were observed over a 28‐d period following the sciatic nerve constriction [chronic constriction injury (CCI) model]. We next determined the effects of central delivery of selective‐NTS2 agonists to CCI‐treated rats on both mechanical allodynia (evoked withdrawal responses) and weight‐bearing deficits (discomfort and quality‐of‐life proxies). The NTS2 analogs JMV431, levocabastine, and β‐lactotensin were all effective in reducing ongoing tactile allodynia in CCI‐treated rats. Likewise, amitriptyline, pregabalin, and morphine significantly attenuated CCI‐induced mechanical hypersensitivity. NTS2 agonists were also efficient in reversing weight‐bearing and postural deficits caused by nerve damage, unlike reference analgesics currently used in the clinic. Thus, NTS2 agonists may offer new treatment avenues for limiting pain associated with peripheral neuropathies and improve functional rehabilitation and well‐being.— Tétreault, P., Beaudet, N., Perron, A., Belleville, K., René, A., Cavelier, F., Martinez, J., Stroh, T., Jacobi, A. M., Rose, S. D., Behlke, M. A., Sarret, P., Spinal NTS2 receptor activation reverses signs of neuropathic pain. FASEB J. 27, 3741–3752 (2013). www.fasebj.orgKeywords
Funding Information
- Canadian Institutes of Health Research
This publication has 92 references indexed in Scilit:
- Conditioned Place Preference Reveals Tonic Pain in an Animal Model of Central PainThe Journal of Pain, 2011
- Neuronal circuitry for pain processing in the dorsal hornNature Reviews Neuroscience, 2010
- Systemically and Topically Active Antinociceptive Neurotensin CompoundsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Identification and Functional Characterization of a Stable, Centrally Active Derivative of the Neurotensin (8−13) Fragment as a Potential First-in-Class AnalgesicJournal of Medicinal Chemistry, 2010
- The acute and subchronic effects of a brain-penetrating, neurotensin-1 receptor agonist on feeding, body weight and temperatureNeuropharmacology, 2010
- NT79: A novel neurotensin analog with selective behavioral effectsBrain Research, 2010
- Unmasking the tonic-aversive state in neuropathic painNature Neuroscience, 2009
- Towards a theory of chronic painProgress in Neurobiology, 2009
- Neurotensin-produced antinociception in the rostral ventromedial medulla is partially mediated by spinal cord norepinephrinePain, 2008
- How many drug targets are there?Nature Reviews Drug Discovery, 2006